Urogen Pharma Ltd. URGN
$30.87
▲ +0.75% 24H
About
UroGen Pharma Ltd. is an Israel-based biopharmaceutical company specializing in innovative treatments for urological cancers and diseases. The company develops therapies using its proprietary RTGel reverse-thermal hydrogel technology, a sustained-release platform that enhances drug delivery directly to targeted tissues…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees298
TickerURGN
Statistics
Market Cap$1.50B
Revenue (TTM)$109.8M
Net Income-$153.5M
Net Margin-139.8%
EPS—
P/E-9.22
P/S10.23
P/B-11.87
EV/EBITDA-13.17
ROE145.5%
Dividend Yield—
Price$30.87
Data: Twelve Data · Revenue = mcap / P/S